- Home
- Pathology Industry
- Multiple Sclerosis Market and Forecasts, May 2013
Industries
- Pathology (128)
- Drug and Medication (62)
- Managed Care (27)
- Pharmaceutical (21)
- Biotechnology (16)
-
- Biological Therapy (11)
- Biopharmaceutical (11)
- Vitamin and Supplement (11)
- Energy & Environment (7)
- Drug Discovery and Development (6)
- Chemical and Material (4)
- Diagnostics (4)
- Genomics (4)
- General Medicine and Specialty Medicine (3)
- Health Insurance (3)
- Healthcare (3)
- Medical Facility (3)
- Advanced Material (2)
- Banking (2)
- Blood Supply, Tissue Banking and Transplantation (2)
Top countries
Publication dates
All regions
-
- Australia (16)
- Belgium (2)
- Canada (15)
- Czech Republic (2)
- Denmark (1)
- France (4)
- Germany (7)
- Greece (2)
- Ireland (1)
- Israel (3)
- Italy (1)
- Japan (7)
- Mexico (1)
- Netherlands (4)
- New Zealand (2)
- Norway (2)
- Portugal (1)
- South Korea (5)
- Spain (4)
- Sweden (1)
- Switzerland (4)
- United Kingdom (17)
- United States (150)
data types
- All
- Company Data (1 027)
- Industry Data
- Country Data (216)
Multiple Sclerosis Market and Forecasts, May 2013
You might be interested in: clinical trial, autoimmune disease, drug, more »
industry reports
country reports
The British Multiple Sclerosis Industry (multiple sclerosis, epstein-barr virus)
- Industry report
- January 2011
- 31 pages
- by Research Paper
... Disease worldwide prevalence patterns in multiple sclerosis Age: migration studies show that the disease is acquired after the age of 15 Sex: the disease is more common on females Race: white people ...
- Industries: Pathology
- Countries: United Kingdom
Multiple Sclerosis Sector Overview (multiple sclerosis, breast cancer, alzheimer's disease)
- Industry report
- January 2011
- 36 pages
... With Bayer (endometriosis) Biogenidec (multiple sclerosis) Suppremol ag (phase ii trial for their novel lupus erythematodes development cand) autoantibodies as companion diagnostics Benlysta ...
- Industries: Pathology
The European Haemophilia Sector (haemophilia, multiple sclerosis, hypertension)
- Industry report
- October 2011
- 23 pages
... Values 0.76 Patients with mild multiple sclerosis (edss 3.0) (1) 0.23 Patients with severe multiple sclerosis (edss 6.5) (1) 1,00 Best health status 0,00 - death appr. 0.43 Patients ...
- Industries: Pathology
- Countries: United Kingdom, Europe, Netherlands
Diabete Industry Overview (diabete, hypertension, multiple sclerosis)
- Industry report
- June 2012
- 45 pages
... Lifestyle 180: disease states Obesity Hyperlipidemia Hypertension Diabetes Non-alcoholic fatty liver disease multiple sclerosis Ulcerative colitis and crohn S disease Prostate ...
- Industries: Pathology
Multiple Sclerosis Market (multiple sclerosis, colorectal cancer, neck cancer) in The United States
- Industry report
- January 2012
- 25 pages
... Strengthened with seasoned senior executives Tough pipeline s taken Continued actions to strengthen and defend leadership positions in multiple sclerosis and oncology Definition of new r ...
- Industries: Pathology
- Countries: United States
Dementia in Australia : Innovation and Technology Trends (dementia, alzheimer's disease, multiple sclerosis)
- Industry report
- August 2011
- 14 pages
... Experience in study design Extensive use in clinical trials (phase 1 Phase 3) Demonstrated operational capability to manage large, international trials in multiple ...
Dementia in Australia : Innovation and Technology Trends (dementia, alzheimer's disease, multiple sclerosis)
- Industry report
- August 2011
- 14 pages
- by Corporation
... Trials in multiple countries and languages 4 for personal use only clinical drug trials Current customers 5 for personal use only market size: clinical ...
Diabete Key Market Figures (diabete, multiple sclerosis, heart failure)
- Industry report
- November 2011
- 60 pages
- by Corporation
... Evidence and clinical expertise informed by the healthcare experience derived from a large population leverages symmetry drug hierarchy - dcc 13circlecopyrt ingenix, inc. 13 Example: multiple sclerosis ...
- Industries: Pathology
Pharmaceutical in The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 191 pages
- by Market Research Publisher
... As being the cause of sma in 1995 >98% of cases attributed to deletions or loss-of-function mutations in smn1 and deficiency of smn protein1 smn protein appears to have multiple functions facilitates ...
- Industries: Pathology
- Countries: United States
Autoimmune Disease Sector (autoimmune disease, cancer, musculoskeletal disorder) in The United States
- Industry report
- January 2012
- 28 pages
... If approved, allow it to be positioned in a variety of autoimmune disorders, including inflammatory bowel diseases and multiple sclerosis as well as other potential disorders such as rheumatoid arthritis ...
- Industries: Pathology
- Countries: United States
» Purchase Premium Reports
About 4 200 reports for Multiple Sclerosis
Reportlinker.com © Copyright 2013. All rights reserved.
